Utibron Neohaler
Generic: indacaterol glycopyrronium
Manufacturer: Novartis · Program:
Apply for AssistanceEligibility Criteria
Insurance Requirement
See program details
Residency
US residency required
Income Threshold
Up to 400% FPL
Individual Income Limit
$58,320/year
Medicare/Medicaid patients may qualify for some Novartis programs
Program Information
Processing Time
2–3 weeks
Delivery Method
shipped to patient or physician office
Application Method
Multiple
Indicated For
COPD
About This Medication
# Novartis Patient Assistance Foundation (NPAF) Patient Guide: How to Get Utibron Neohaler at Low or No Cost Utibron Neohaler (indacaterol glycopyrronium) is a prescription inhaler used to manage chronic obstructive pulmonary disease (COPD), combining two bronchodilators to help open airways and ease breathing for better daily comfort.[1][4] The **Novartis Patient Assistance Foundation (NPAF)** offers this medication **free** to eligible patients facing financial hardship with limited or no prescription insurance.[1][4][9] ## About Utibron Neohaler **Utibron Neohaler** is a maintenance treatment for COPD, a lung condition causing breathing difficulties, cough, and fatigue. It contains **indacaterol** (a long-acting beta-agonist) and **glycopyrronium** (a long-acting muscarinic antagonist), which relax airway muscles for up to 24 hours per dose. Patients typically inhale one capsule daily using the Neohaler device. It's not for sudden symptoms—use a rescue inhaler like albuterol for those. Always follow your doctor's instructions, as COPD management often includes quitting smoking, exercise, and vaccinations.[1][4][8] ## Who Qualifies for NPAF? NPAF targets patients who can't afford Novartis medicines like Utibron Neohaler. Key requirements include: - **Residency**: Live in the US or a US Territory.[1][4] - **Healthcare**: Treated outpatient by a licensed US provider.[1][4] - **Insurance**: Limited or **no prescription drug coverage** (public or private). Medicare Part D or commercial plans often disqualify unless coverage is inadequate and documented.[1][4][9] - **Income**: Meet **household income guidelines** (varies by drug, household size, state). Alaska/Hawaii have higher limits. Exact Utibron thresholds aren't listed publicly—check www.PAP.Novartis.com for your situation.[1][4][8] - **Prescription**: Valid US prescription for Utibron Neohaler.[4] **Note**: Programs evaluate case-by-case. Third parties like pharmacies can't enroll you.[1] ## Income Eligibility Breakdown NPAF bases eligibility on **federal poverty level (FPL)** or fixed limits, adjusted yearly. For Utibron Neohaler, visit www.PAP.Novartis.com to verify current guidelines by household size and location. Example thresholds from similar programs (confirm for accuracy): | Household Size | Example Annual Income Limit (Contiguous US) | Alaska/Hawaii Adjustment | |----------------|---------------------------------------------|--------------------------| | 1 (Individual) | Up to ~$30,000-$40,000 | Higher by ~25-40% | | 2 (Couple) | Up to ~$40,000-$60,000 | Higher by ~25-40% | | 3 | Up to ~$50,000-$75,000 | Higher by ~25-40% | | 4 | Up to ~$60,000-$100,000 | Higher by ~25-40% | *Add ~$5,000-$10,000 per extra member. These are illustrative—**use the eligibility tool** for precise Utibron figures.[1][4][8][9] Income includes wages, Social Security, etc. Provide proof like tax returns. ## Insurance Requirements NPAF is for those with **no or limited prescription coverage**.[9] If insured: - Submit proof of denial, prior authorization (PA), or appeal outcomes.[5] - Medicare patients: May need **Extra Help denial** letter.[1] - Commercial insurance: Program excludes those with active coverage; co-pay programs exist separately.[3][6] Uninsured or underinsured patients qualify easiest. NPAF verifies coverage.[1][4] ## Step-by-Step Application Process 1. **Check Eligibility**: Go to www.PAP.Novartis.com. Enter household size, income, insurance status, and Utibron Neohaler to pre-screen.[1][4] 2. **Gather Documents**: Prescription, proof of income (e.g., 2025 tax return, pay stubs, SSI award), residency proof, insurance denial/Extra Help letter if applicable.[1][4] 3. **Complete Application**: Download English/Spanish forms from www.PAP.Novartis.com or Novartis site. **Patient** fills personal/financial section; **doctor** completes medical part. Mark N/A if needed.[4][5][9] 4. **Submit**: Mail to Novartis Patient Assistance Foundation, P.O. Box 66556, St. Louis, MO 63166-6556. Or call 1-800-277-2254 for help.[9] 5. **Follow Up**: Opt in for texts. Incomplete apps get a letter with instructions.[1] **Tip**: Apply early. Doctor's office can assist.[7] ## Timeline and Delivery - **Processing**: Up to **4 weeks** for decision letter.[1] - **Delivery**: If approved, free medication ships directly to your home or doctor's office. Supply duration varies (e.g., 1-12 months).[1][7] - **Refills**: Reapply or reauthorize as needed—no fixed schedule listed.[1] ## Alternatives if Denied - **Appeal**: Review denial letter; resubmit missing docs.[1] - **Co-Pay Programs**: For insured patients, check Novartis co-pay options (PDF on site).[3] - **Third-Party Help**: Simplefill (877-386-0206) or Rx Advocates match to programs.[6][8] - **State Programs**: Search state pharmaceutical aid. - **Generic Options**: No biosimilars listed; discuss alternatives like other LABA/LAMA inhalers (e.g., Anoro Ellipta) with your doctor. - **Extra Help**: Apply for Medicare low-income subsidy if eligible. ## Disclaimer This guide summarizes public info as of available data. **NPAF can change rules, income limits, or coverage anytime** without notice.[1] Utibron Neohaler eligibility varies—**always verify at www.PAP.Novartis.com or call 1-800-277-2254**.[9] Not medical/financial advice. Consult your doctor for treatment; financial advisor for income questions. Novartis reserves verification rights. Word count: ~950.
Program information last verified: March 30, 2026
Ready to apply for Utibron Neohaler assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.